Aspirin in Reducing Events in the Elderly international study consortium

Aspirin in Reducing Events in the Elderly international study consortium

ASPREE (ASPirin in Reducing Events in the Elderly) is a USD$50 million international collaborative project led by Monash University and funded by the USA and Australian governments.

The project draws together scientific research strengths across universities, Australian general practitioners (GPs) and healthy older people.

The ASPREE project will determine whether taking a daily low-dose aspirin prevents or delays the onset of age-related illness such as cardiovascular disease (heart attack and stroke), dementia and depression. It also examines whether the benefits outweigh the risks associated with taking regaulr asprin.

Professor John McNeil, Head of the School of Public Health and preventive Medicine at Monash University, co-chairs the ASPREE International Steering Committee. As co-principal investigator on the study, Prof McNeil was instrumental developing and establishing this internationally important clinical program.

The project’s funding is due in large part to the team’s prolific public health research achievements, clinical expertise, database and registry management experience.

Find out more about ASPREE